☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
Minnesota |
41-1597886 |
|
(State or other jurisdiction of incorporation or
organization)
|
(I.R.S. Employer Identification No.) |
1001 Third Avenue South |
||||
Minneapolis, |
Minnesota |
55404 |
||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading
Symbol(s)
|
Name of each exchange on which registered |
||
Common Stock, par value $0.01 per share |
SNBR |
Nasdaq Global Select Market |
Large accelerated filer |
☐ |
Accelerated filer |
☒ |
|
Non-accelerated filer |
☐ |
Smaller reporting company |
☐ |
|
Emerging growth company |
☐ |
i | 3Q 2023 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Page |
||
1 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
September 28,
2024
|
December 30,
2023
|
||
Assets |
|||
Current assets: |
|||
Cash and cash equivalents |
$1,592 |
$2,539 |
|
Accounts receivable, net of allowances of $1,134 and $1,437, respectively |
17,026 |
26,859 |
|
Inventories |
93,039 |
115,433 |
|
Prepaid expenses |
17,827 |
16,660 |
|
Other current assets |
40,784 |
44,637 |
|
Total current assets |
170,268 |
206,128 |
|
Non-current assets: |
|||
Property and equipment, net |
140,406 |
179,503 |
|
Operating lease right-of-use assets |
367,133 |
395,411 |
|
Goodwill and intangible assets, net |
66,468 |
66,634 |
|
Deferred income taxes |
27,267 |
20,253 |
|
Other non-current assets |
93,109 |
82,951 |
|
Total assets |
$864,651 |
$950,880 |
|
Liabilities and Shareholders’ Deficit |
|||
Current liabilities: |
|||
Borrowings under revolving credit facility |
$516,500 |
$539,500 |
|
Accounts payable |
127,990 |
135,901 |
|
Customer prepayments |
43,514 |
49,143 |
|
Accrued sales returns |
19,688 |
22,402 |
|
Compensation and benefits |
28,909 |
28,273 |
|
Taxes and withholding |
17,685 |
17,134 |
|
Operating lease liabilities |
82,488 |
81,760 |
|
Other current liabilities |
57,268 |
61,958 |
|
Total current liabilities |
894,042 |
936,071 |
|
Non-current liabilities: |
|||
Operating lease liabilities |
318,665 |
351,394 |
|
Other non-current liabilities |
100,728 |
105,343 |
|
Total liabilities |
1,313,435 |
1,392,808 |
|
Shareholders’ deficit: |
|||
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding |
— |
— |
|
Common stock, $0.01 par value; 142,500 shares authorized, 22,371 and 22,235 shares issued
and outstanding, respectively
|
224 |
222 |
|
Additional paid-in capital |
25,527 |
16,716 |
|
Accumulated deficit |
(474,535) |
(458,866) |
|
Total shareholders’ deficit |
(448,784) |
(441,928) |
|
Total liabilities and shareholders’ deficit |
$864,651 |
$950,880 |
2 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Net sales |
$426,617 |
$472,648 |
$1,305,479 |
$1,457,964 |
|||
Cost of sales |
167,089 |
201,537 |
528,287 |
612,343 |
|||
Gross profit |
259,528 |
271,111 |
777,192 |
845,621 |
|||
Operating expenses: |
|||||||
Sales and marketing |
205,480 |
221,143 |
596,392 |
649,410 |
|||
General and administrative |
33,070 |
31,948 |
111,722 |
111,144 |
|||
Research and development |
10,583 |
12,633 |
34,602 |
42,521 |
|||
Restructuring costs |
1,963 |
— |
14,382 |
— |
|||
Total operating expenses |
251,096 |
265,724 |
757,098 |
803,075 |
|||
Operating income |
8,432 |
5,387 |
20,094 |
42,546 |
|||
Interest expense, net |
12,057 |
10,958 |
36,626 |
30,008 |
|||
(Loss) income before income taxes |
(3,625) |
(5,571) |
(16,532) |
12,538 |
|||
Income tax (benefit) expense |
(489) |
(3,253) |
(863) |
2,637 |
|||
Net (loss) income |
$(3,136) |
$(2,318) |
$(15,669) |
$9,901 |
|||
Basic net (loss) income per share: |
|||||||
Net (loss) income per share – basic |
$(0.14) |
$(0.10) |
$(0.69) |
$0.44 |
|||
Weighted-average shares – basic |
22,643 |
22,479 |
22,588 |
22,412 |
|||
Diluted net (loss) income per share: |
|||||||
Net (loss) income per share – diluted |
$(0.14) |
$(0.10) |
$(0.69) |
$0.44 |
|||
Weighted-average shares – diluted |
22,643 |
22,479 |
22,588 |
22,558 |
3 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Common Stock |
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total |
||||||
Shares |
Amount |
||||||||
Balance at December 30, 2023 |
22,235 |
$222 |
$16,716 |
$(458,866) |
$(441,928) |
||||
Net loss |
— |
— |
— |
(7,482) |
(7,482) |
||||
Stock-based compensation |
134 |
1 |
4,116 |
— |
4,117 |
||||
Repurchases of common stock |
(43) |
— |
(570) |
— |
(570) |
||||
Balance at March 30, 2024 |
22,326 |
$223 |
$20,262 |
$(466,348) |
$(445,863) |
||||
Net loss |
— |
— |
— |
(5,051) |
(5,051) |
||||
Stock-based compensation |
32 |
1 |
3,991 |
— |
3,992 |
||||
Repurchases of common stock |
(3) |
— |
(42) |
— |
(42) |
||||
Balance at June 29, 2024 |
22,355 |
$224 |
$24,211 |
$(471,399) |
$(446,964) |
||||
Net loss |
— |
— |
— |
(3,136) |
(3,136) |
||||
Stock-based compensation |
24 |
— |
1,432 |
— |
1,432 |
||||
Repurchases of common stock |
(8) |
— |
(116) |
— |
(116) |
||||
Balance at September 28, 2024 |
22,371 |
$224 |
$25,527 |
$(474,535) |
$(448,784) |
Common Stock |
Additional
Paid-in
Capital
|
Accumulated
Deficit
|
Total |
||||||
Shares |
Amount |
||||||||
Balance at December 31, 2022 |
22,014 |
$220 |
$5,182 |
$(443,579) |
$(438,177) |
||||
Net income |
— |
— |
— |
11,465 |
11,465 |
||||
Exercise of common stock options |
17 |
— |
389 |
— |
389 |
||||
Stock-based compensation |
271 |
3 |
4,636 |
— |
4,639 |
||||
Repurchases of common stock |
(118) |
(1) |
(3,362) |
— |
(3,363) |
||||
Balance at April 1, 2023 |
22,184 |
$222 |
$6,845 |
$(432,114) |
$(425,047) |
||||
Net income |
— |
— |
— |
754 |
754 |
||||
Exercise of common stock options |
3 |
— |
39 |
— |
39 |
||||
Stock-based compensation |
33 |
— |
5,251 |
— |
5,251 |
||||
Repurchases of common stock |
(6) |
— |
(138) |
— |
(138) |
||||
Balance at July 1, 2023 |
22,214 |
$222 |
$11,997 |
$(431,360) |
$(419,141) |
||||
Net loss |
— |
— |
— |
(2,318) |
(2,318) |
||||
Stock-based compensation |
22 |
— |
982 |
— |
982 |
||||
Repurchases of common stock |
(8) |
— |
(210) |
— |
(210) |
||||
Balance at September 30, 2023 |
22,228 |
$222 |
$12,769 |
$(433,678) |
$(420,687) |
4 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Nine Months Ended |
|||
September 28,
2024
|
September 30,
2023
|
||
Cash flows from operating activities: |
|||
Net (loss) income |
$(15,669) |
$9,901 |
|
Adjustments to reconcile net (loss) income to net cash provided by
operating activities:
|
|||
Depreciation and amortization |
50,379 |
55,196 |
|
Stock-based compensation |
9,541 |
10,872 |
|
Net loss on disposals and impairments of assets |
2,457 |
464 |
|
Deferred income taxes |
(7,014) |
(13,433) |
|
Changes in operating assets and liabilities: |
|||
Accounts receivable |
9,833 |
7,374 |
|
Inventories |
22,394 |
(2,190) |
|
Income taxes |
1,708 |
3,571 |
|
Prepaid expenses and other assets |
(8,012) |
(5,903) |
|
Accounts payable |
4,980 |
5,199 |
|
Customer prepayments |
(5,629) |
(27,279) |
|
Accrued compensation and benefits |
788 |
(6,923) |
|
Other taxes and withholding |
(1,157) |
5 |
|
Other accruals and liabilities |
(13,775) |
(5,038) |
|
Net cash provided by operating activities |
50,824 |
31,816 |
|
Cash flows from investing activities: |
|||
Purchases of property and equipment |
(17,218) |
(48,022) |
|
Issuance of note receivable |
(2,942) |
(1,317) |
|
Proceeds from sales of property and equipment |
156 |
10 |
|
Net cash used in investing activities |
(20,004) |
(49,329) |
|
Cash flows from financing activities: |
|||
Net (decrease) increase in short-term borrowings |
(31,039) |
20,334 |
|
Repurchases of common stock |
(728) |
(3,711) |
|
Proceeds from issuance of common stock |
— |
428 |
|
Debt issuance costs |
— |
(424) |
|
Net cash (used in) provided by financing activities |
(31,767) |
16,627 |
|
Net decrease in cash and cash equivalents |
(947) |
(886) |
|
Cash and cash equivalents, at beginning of period |
2,539 |
1,792 |
|
Cash and cash equivalents, at end of period |
$1,592 |
$906 |
5 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
6 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
September 28,
2024
|
December 30,
2023
|
||
Raw materials |
$6,638 |
$9,092 |
|
Work in progress |
133 |
92 |
|
Finished goods |
86,268 |
106,249 |
|
$93,039 |
$115,433 |
7 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
2024 (excluding the nine months ended September 28, 2024 ) |
$55 |
|
2025 |
226 |
|
2026 |
222 |
|
2027 |
222 |
|
2028 |
155 |
|
2029 |
99 |
|
Thereafter |
46 |
|
Total future amortization for definite-lived intangible assets |
$1,025 |
September 28,
2024
|
December 30,
2023
|
||
Outstanding borrowings |
$516,500 |
$539,500 |
|
Outstanding letters of credit |
$7,147 |
$7,147 |
|
Additional borrowing capacity |
$156,353 |
$138,353 |
|
Weighted-average interest rate |
8.2% |
8.5% |
8 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Operating lease costs(1) |
$26,445 |
$28,517 |
$80,180 |
$84,889 |
|||
Variable lease costs(2) |
$42 |
$48 |
$1 |
$230 |
2024 (excluding the nine months ended September 28, 2024) |
$26,997 |
2025 |
103,848 |
2026 |
91,716 |
2027 |
75,205 |
2028 |
63,060 |
2029 |
43,265 |
Thereafter |
73,361 |
Total operating lease payments(2) |
477,452 |
Less: Interest |
76,299 |
Present value of operating lease liabilities |
$401,153 |
September 28,
2024
|
December 30,
2023
|
|||
Weighted-average remaining lease term (in years) |
5.5 |
5.9 |
||
Weighted-average discount rate |
6.6% |
6.5% |
9 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Nine Months Ended |
||||
(in thousands) |
September 28,
2024
|
September 30,
2023
|
||
Cash paid for amounts included in present value of operating lease liabilities |
$81,089 |
$80,650 |
||
Right-of-use assets obtained in exchange for operating lease liabilities |
$29,390 |
$54,172 |
September 28,
2024
|
December 30,
2023
|
||
Deferred contract assets included in: |
|||
Other current assets |
$30,329 |
$28,567 |
|
Other non-current assets |
50,981 |
54,795 |
|
$81,310 |
$83,362 |
September 28,
2024
|
December 30,
2023
|
||
Deferred contract liabilities included in: |
|||
Other current liabilities |
$38,395 |
$36,421 |
|
Other non-current liabilities |
63,594 |
69,098 |
|
$101,989 |
$105,519 |
10 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Retail stores |
$374,593 |
$409,268 |
$1,147,931 |
$1,270,076 |
|||
Online, phone, chat and other |
52,024 |
63,380 |
157,548 |
187,888 |
|||
Total Company |
$426,617 |
$472,648 |
$1,305,479 |
$1,457,964 |
Nine Months Ended |
|||
September 28,
2024
|
September 30,
2023
|
||
Balance at beginning of year |
$22,402 |
$25,594 |
|
Additions that reduce net sales |
69,391 |
82,718 |
|
Deductions from reserves |
(72,105) |
(85,300) |
|
Balance at end of period |
$19,688 |
$23,012 |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Stock awards (1) |
$774 |
$(82) |
7,212 |
$8,031 |
|||
Stock options |
658 |
1,064 |
2,329 |
2,841 |
|||
Total stock-based compensation expense (1) |
1,432 |
982 |
9,541 |
10,872 |
|||
Income tax benefit |
285 |
118 |
2,004 |
1,305 |
|||
Total stock-based compensation expense,
net of tax
|
$1,147 |
$864 |
$7,537 |
$9,567 |
11 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Net (loss) income |
$(3,136) |
$(2,318) |
$(15,669) |
$9,901 |
|||
Reconciliation of weighted-average shares outstanding: |
|||||||
Basic weighted-average shares outstanding |
22,643 |
22,479 |
22,588 |
22,412 |
|||
Dilutive effect of stock-based awards |
— |
— |
— |
146 |
|||
Diluted weighted-average shares outstanding |
22,643 |
22,479 |
22,588 |
22,558 |
|||
Net (loss) income per share – basic |
$(0.14) |
$(0.10) |
$(0.69) |
$0.44 |
|||
Net (loss) income per share – diluted |
$(0.14) |
$(0.10) |
$(0.69) |
$0.44 |
Three Months Ended |
Nine Months Ended |
||
September 28,
2024
|
September 28,
2024
|
||
Cash restructuring costs: |
|||
Contract termination costs (1) |
$300 |
$4,483 |
|
Severance and employee-related benefits |
1,663 |
2,905 |
|
Professional fees and other |
— |
4,494 |
|
Total cash restructuring costs |
1,963 |
11,882 |
|
Non-cash restructuring costs: |
|||
Asset impairments (2) |
— |
2,500 |
|
Total restructuring costs |
$1,963 |
$14,382 |
12 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Nine Months Ended |
|||
September 28,
2024
|
|||
Balance at the beginning of year |
$8,720 |
||
Expenses |
11,882 |
||
Cash payments |
(19,282) |
||
Balance at the end of the period |
$1,320 |
Cumulative |
||
September 28,
2024
|
||
Cash restructuring costs: |
||
Contract termination costs (1) |
$11,893 |
|
Severance and employee-related benefits |
7,871 |
|
Professional fees and other |
5,604 |
|
Total cash restructuring costs |
25,368 |
|
Non-cash restructuring costs: |
||
Asset impairments (2) |
4,742 |
|
Total restructuring costs |
$30,110 |
Nine Months Ended |
|||
September 28,
2024
|
September 30,
2023
|
||
Balance at beginning of period |
$8,503 |
$8,997 |
|
Additions charged to costs and expenses for current-year sales |
9,981 |
12,327 |
|
Deductions from reserves |
(11,546) |
(12,543) |
|
Changes in liability for pre-existing warranties during the current year, including
expirations
|
511 |
40 |
|
Balance at end of period |
$7,449 |
$8,821 |
13 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
14 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
15 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
16 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
17 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
18 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Nine Months Ended |
||||||||||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||||||||||
Net sales |
$426.6 |
100.0% |
$472.6 |
100.0% |
$1,305.5 |
100.0% |
$1,458.0 |
100.0% |
|||||||
Cost of sales |
167.1 |
39.2% |
201.5 |
42.6% |
528.3 |
40.5% |
612.3 |
42.0% |
|||||||
Gross profit |
259.5 |
60.8% |
271.1 |
57.4% |
777.2 |
59.5% |
845.6 |
58.0% |
|||||||
Operating expenses: |
|||||||||||||||
Sales and marketing |
205.5 |
48.2% |
221.1 |
46.8% |
596.4 |
45.7% |
649.4 |
44.5% |
|||||||
General and administrative |
33.1 |
7.8% |
31.9 |
6.8% |
111.7 |
8.6% |
111.1 |
7.6% |
|||||||
Research and development |
10.6 |
2.5% |
12.6 |
2.7% |
34.6 |
2.7% |
42.5 |
2.9% |
|||||||
Restructuring costs |
2.0 |
0.5% |
— |
0.0% |
14.4 |
1.1% |
— |
0.0% |
|||||||
Total operating expenses |
251.1 |
58.9% |
265.7 |
56.2% |
757.1 |
58.0% |
803.1 |
55.1% |
|||||||
Operating income |
8.4 |
2.0% |
5.4 |
1.1% |
20.1 |
1.5% |
42.5 |
2.9% |
|||||||
Interest expense, net |
12.1 |
2.8% |
11.0 |
2.3% |
36.6 |
2.8% |
30.0 |
2.1% |
|||||||
(Loss) income before income
taxes
|
(3.6) |
(0.8%) |
(5.6) |
(1.2%) |
(16.5) |
(1.3%) |
12.5 |
0.9% |
|||||||
Income tax (benefit) expense |
(0.5) |
(0.1%) |
(3.3) |
(0.7%) |
(0.9) |
(0.1%) |
2.6 |
0.2% |
|||||||
Net (loss) income |
$(3.1) |
(0.7%) |
$(2.3) |
(0.5%) |
$(15.7) |
(1.2%) |
$9.9 |
0.7% |
|||||||
Net (loss) income per share: |
|||||||||||||||
Basic |
$(0.14) |
$(0.10) |
$(0.69) |
$0.44 |
|||||||||||
Diluted |
$(0.14) |
$(0.10) |
$(0.69) |
$0.44 |
|||||||||||
Weighted-average number of common shares: |
|||||||||||||||
Basic |
22.6 |
22.5 |
22.6 |
22.4 |
|||||||||||
Diluted |
22.6 |
22.5 |
22.6 |
22.6 |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Retail stores |
87.8% |
86.6% |
87.9% |
87.1% |
|||
Online, phone, chat and other |
12.2% |
13.4% |
12.1% |
12.9% |
|||
Total Company |
100.0% |
100.0% |
100.0% |
100.0% |
19 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Sales change rates: |
|||||||
Retail comparable-store sales (1) |
(7%) |
(14%) |
(9%) |
(11%) |
|||
Online, phone and chat |
(18%) |
(14%) |
(17%) |
(13%) |
|||
Total Retail comparable sales change (1) |
(9%) |
(14%) |
(10%) |
(11%) |
|||
Net opened/closed stores and other |
(1%) |
1% |
0% |
1% |
|||
Total Company |
(10%) |
(13%) |
(10%) |
(10%) |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Average sales per store (1) (in thousands) |
$2,670 |
$2,952 |
|||||
Average sales per square foot (1) |
$863 |
$963 |
|||||
Stores > $2 million in net sales (2) |
60% |
67% |
|||||
Stores > $3 million in net sales (2) |
20% |
27% |
|||||
Average revenue per smart bed unit (3) |
$5,771 |
$5,640 |
$5,778 |
$5,822 |
Three Months Ended |
Nine Months Ended |
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Beginning of period |
646 |
672 |
672 |
670 |
|||
Opened |
1 |
8 |
11 |
27 |
|||
Closed |
(4) |
(2) |
(40) |
(19) |
|||
End of period |
643 |
678 |
643 |
678 |
20 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
21 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
22 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
23 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Nine Months Ended |
|||
September 28,
2024
|
September 30,
2023
|
||
Total cash provided by (used in): |
|||
Operating activities |
$50.8 |
$31.8 |
|
Investing activities |
(20.0) |
(49.3) |
|
Financing activities |
(31.8) |
16.6 |
|
Net decrease in cash and cash equivalents |
$(0.9) |
$(0.9) |
24 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Three Months Ended |
Trailing-Twelve
Months Ended
|
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Net (loss) income |
$(3,136) |
$(2,318) |
$(40,857) |
$4,471 |
|||
Income tax (benefit) expense |
(489) |
(3,253) |
(7,966) |
1,346 |
|||
Interest expense |
12,057 |
10,958 |
49,313 |
37,641 |
|||
Depreciation and amortization |
15,859 |
18,200 |
67,335 |
72,338 |
|||
Stock-based compensation |
1,432 |
982 |
13,523 |
15,511 |
|||
Restructuring costs |
1,963 |
— |
30,110 |
— |
|||
Asset impairments |
— |
292 |
198 |
491 |
|||
Adjusted EBITDA |
$27,686 |
$24,861 |
$111,656 |
$131,798 |
Nine Months Ended |
Trailing-Twelve
Months Ended
|
||||||
September 28,
2024
|
September 30,
2023
|
September 28,
2024
|
September 30,
2023
|
||||
Net cash provided by (used in) operating
activities
|
$50,824 |
$31,816 |
$9,980 |
$(12,168) |
|||
Subtract: Purchases of property and
equipment
|
17,218 |
48,022 |
26,252 |
64,668 |
|||
Free cash flow |
$33,606 |
$(16,206) |
$(16,272) |
$(76,836) |
25 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Trailing-Twelve Months Ended |
|||
September 28,
2024
|
September 30,
2023
|
||
Adjusted net operating profit after taxes (Adjusted NOPAT) |
|||
Operating income |
$490 |
$43,458 |
|
Add: Operating lease expense (1) |
27,371 |
27,497 |
|
Less: Income taxes (2) |
(5,474) |
(1,168) |
|
Adjusted NOPAT |
$22,387 |
$69,787 |
|
Average adjusted invested capital |
|||
Total deficit |
$(448,784) |
$(420,687) |
|
Add: Long-term debt (3) |
516,761 |
488,338 |
|
Add: Operating lease obligations (4) |
401,153 |
439,722 |
|
Total adjusted invested capital at end of period |
$469,130 |
$507,373 |
|
Average adjusted invested capital (5) |
$502,494 |
$469,782 |
|
Adjusted return on invested capital (Adjusted ROIC) (6) |
4.5% |
14.9% |
26 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
27 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
28 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Period |
Total
Number
of Shares
Purchased(1)(2)
|
Average
Price
Paid per
Share
|
Total Number
of
Shares
Purchased
as Part of
Publicly
Announced
Plans
or Programs(1)
|
Approximate
Dollar Value of
Shares that May
Yet Be Purchased
Under the Plans
or Programs(3)
|
||||
June 30, 2024 through July 27, 2024 |
67 |
$8.63 |
— |
$348,071,000 |
||||
July 28, 2024 through August 24, 2024 |
3,687 |
$12.13 |
— |
$348,071,000 |
||||
August 25, 2024 through September 28, 2024 |
4,232 |
$16.71 |
— |
$348,071,000 |
||||
Total |
7,986 |
$14.53 |
— |
$348,071,000 |
29 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
Exhibit
Number
|
Description |
|
10.1† |
||
31.1* |
||
31.2* |
||
32.1* |
||
32.2* |
||
101.INS* |
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document
|
|
101.SCH* |
Inline XBRL Taxonomy Extension Schema Document |
|
101.CAL* |
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
|
101.DEF* |
Inline XBRL Taxonomy Extension Definition Linkbase Document |
|
101.LAB* |
Inline XBRL Taxonomy Extension Label Linkbase Document |
|
101.PRE* |
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
|
104* |
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
30 | 3Q 2024 FORM 10-Q |
SLEEP NUMBER CORPORATION |
SLEEP NUMBER CORPORATION |
|||
(Registrant) |
|||
Dated: |
November 5, 2024 |
By: |
/s/ Shelly R. Ibach |
Shelly R. Ibach |
|||
Chief Executive Officer |
|||
(principal executive officer) |
|||
By: |
/s/ Joel J. Laing |
||
Joel J. Laing |
|||
Chief Accounting Officer |
|||
(principal accounting officer) |
Date: November 5, 2024 | |||||
/s/ Shelly R. Ibach | |||||
Shelly R. Ibach | |||||
Chief Executive Officer |
Date: November 5, 2024 | |||||
/s/ Francis K. Lee | |||||
Francis K. Lee | |||||
Executive Vice President and Chief Financial Officer |
Date: November 5, 2024 | |||||
/s/ Shelly R. Ibach | |||||
Shelly R. Ibach | |||||
Chief Executive Officer |
Date: November 5, 2024 | |||||
/s/ Francis K. Lee | |||||
Francis K. Lee | |||||
Executive Vice President and Chief Financial Officer |